Skip to Content

Month: February 2022

What science has learned about COVID-19 immunity amid Delta, Omicron waves

By Brooklyn Neustaeter Click here for updates on this story     TORONTO (CTV Network) — As the COVID-19 pandemic evolves and more variants emerge, experts say it is unclear whether the immunity developed during infection, regardless of vaccination status, may provide long-term, individual protection against future waves. Since the early days of the COVID-19 pandemic, experts

Continue Reading

Amid scrambles for teachers, some fear worse shortages ahead

By MARK SCOLFORO Associated Press HARRISBURG, Pa. (AP) — U.S. school administrators dealing with pandemic-driven teacher shortages are getting creative to keep their classrooms staffed. But some experts are warning there are longer-term problems with the teacher pipeline that cannot be solved with emergency substitutes, bonuses and loosened qualifications. Shortages are being felt much more

Continue Reading
Helen McCrory

‘Very strange’ to be on ‘Peaky Blinders’ set without Helen McCrory, Cillian Murphy says

By Sara Spary, CNN Irish actor Cillian Murphy has said it was “very strange” to film the final series of “Peaky Blinders” without Helen McCrory, as he remembered his “brave” and “magnificent” former co-star. Murphy, who plays protagonist Tommy Shelby in the hit series, said in an interview with Esquire on Tuesday that McCrory was

Continue Reading

Merck has strong fourth quarter as COVID-19 treatment debuts

By TOM MURPHY AP Health Writer The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker’s COVID-19 treatment debuted with nearly $1 billion in sales. A 50% jump in sales for the Gardasil vaccine, which protects against cancer-causing human papilloma virus infections, also helped, Merck said Thursday. Overall, Merck earned $3.76 billion

Continue Reading
Skip to content